Should You Continue Taking Esomeprazole?
Yes, you should continue taking esomeprazole for maintenance therapy given your erosive gastritis and hiatal hernia, as discontinuation will likely result in symptom recurrence and disease relapse.
Why Maintenance Therapy is Necessary
For patients with erosive gastritis (erosive esophagitis) and hiatal hernia, the evidence strongly supports continuous PPI therapy rather than stopping treatment 1. Here's the clinical reasoning:
High Risk of Recurrence Without Treatment
Erosive disease recurs rapidly when PPIs are discontinued. Studies show that patients not maintained on continuous acid suppression have high rates of recurrence of erosive disease 1.
Hiatal hernia significantly reduces PPI efficacy at standard doses. Research demonstrates that standard-dose esomeprazole (40 mg once daily) fails to normalize esophageal pH in almost 50% of patients with hiatal hernia 2. This means your hiatal hernia makes you particularly dependent on adequate PPI therapy.
87.5% of patients who stop PPIs after achieving remission experience symptom recurrence, and all exhibited histological recurrence in one study 3.
The Evidence for Long-Term Maintenance
The American Gastroenterological Association (2008) provides Grade A recommendation (strongest level) for long-term use of PPIs in patients with esophagitis once clinically effective 1. The decision is driven by symptom control and quality of life rather than preventing long-term complications.
Key findings supporting maintenance therapy:
- Over 90% of patients maintain healing with esomeprazole 20-40 mg daily over 6 months 4
- Daily therapy is superior to on-demand therapy for maintaining healed erosive esophagitis (81% vs 58% remission at 6 months) 5
- Long-term studies show sustained symptom control and quality of life with esomeprazole 20 mg daily over 5 years 6
Optimal Dosing Strategy
For Your Specific Conditions
Given your hiatal hernia plus erosive gastritis, you likely need:
Higher initial doses: Patients with hiatal hernia often require esomeprazole 40 mg twice daily (not just once daily) to achieve adequate acid control 2
Maintenance dosing: Once symptoms are controlled, the dose should be titrated to the lowest effective dose 1, 7
- Many patients can maintain remission on esomeprazole 20 mg once daily
- However, those with hiatal hernia may need to remain on 40 mg once or twice daily
Do not use on-demand therapy: For patients with proven erosive disease, on-demand therapy cannot be recommended as recurrence rates are unacceptably high 1, 5
Important Caveats
When to Reassess
- Periodic dose re-evaluation is essential to ensure you're on the lowest effective dose 7
- If you've been on PPIs empirically without endoscopic confirmation of erosive disease, consider endoscopy with 96-hour wireless pH monitoring off medication to confirm the appropriateness of long-term therapy 8
What NOT to Do
- Do not reduce to less than daily dosing if you have documented erosive esophagitis 1
- Do not stop abruptly without medical supervision, as this will likely result in rapid symptom return
- Avoid dose reduction in primary care without specialist input, especially given your hiatal hernia 3
Monitoring Considerations
According to 2017 AGA expert review 7:
- You do NOT need routine monitoring of bone density, vitamin B12, magnesium, or creatinine
- You do NOT need to increase calcium, B12, or magnesium beyond recommended dietary allowances
- The benefits of continued therapy outweigh theoretical long-term risks in patients with documented erosive disease
The Bottom Line
Your combination of erosive gastritis and hiatal hernia creates a high-risk scenario for disease recurrence if PPIs are stopped. The main risk of discontinuing therapy is recurrent symptoms and erosive disease, not long-term complications from continuing treatment. The decision should be based on maintaining your quality of life through adequate symptom control 1.
Work with your physician to ensure you're on the optimal maintenance dose—likely esomeprazole 20-40 mg daily—but do not discontinue therapy without objective testing to confirm it's safe to do so.